Arkolith/Insider Trading/RLAY/Form 4

Rahmer Peter

See remarksRelay Therapeutics, Inc. (RLAY) · full profile →Form 4 · filed Jul 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$955K
Net Open-Market Flow
-$955K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2026Sell(S)50K$19.09$955K226K
Jun 30, 2026Grant(A)3K$6.95$21K229K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-294528) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML